Ann: Appendix 4C - quarterly, page-10

I think this stock is far from a dog. it has great prospects. Did you read it had signed a major screening programme? That’s an entire country potentially.

It continues to hit targets. it continues to sell. It was able to raise $50M to sophisticated investors and are already merging with others (ready buying) to expand market.

The company continues to exceed the corresponding quarter (year before) by over 100%

I would like to see (mainly because I am lazy) them produce and report on the growth quarter to quarter in ARR and ARPU.

I think they are doing well. Are yet overvalued - they are not making money but their share of the market is hugely promising with lots of potential.

I thought XRO was over rated at $4 NZ - so I have learnt my lesson.